Conor Medsystems Clinical Trials
Sponsors / Conor Medsystems
The ClinicalTrials.gov registry records 10 trials led by Conor Medsystems. 0 trials are actively recruiting participants, 0 remain active without open enrollment, and 4 have concluded. 6 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include safety concerns, efficacy or futility findings. The cumulative planned enrollment figure across all listed trials is 2,932 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
10
Total Trials
0
Recruiting
0
Other Active
4
Completed
6
Terminated / Withdrawn
2,932
Total Enrollment
Termination reasons: Other50% · Safety33% · Efficacy17%
Recent Terminations
- Coronary Disease"The NEVO™ stent will not be commercialized. Cordis decided to close the study after 3 years. This decision took the absence of safety signals into account."
- Coronary Atherosclerosis"The NEVO™ stent will not be commercialized. Cordis have decided to close the study after 3 years. This decision took the absence of safety signals into account."
- Coronary Disease
- Coronary Artery Disease
- Coronary Disease
- Symptomatic Ischemic Heart Disease"CoStar Stent IDE failed to meet primary endpoint"